Overview
Boomerang Medical is a pioneering women-led bioelectronic medicine company headquartered in Mountain View, California. This innovative organization focuses on advancing treatment options for autoimmune diseases, particularly targeting Inflammatory Bowel Disease (IBD) through neuromodulation technologies. The company benefits from being a Company-In-Residence at the prestigious Fogarty Innovation incubator, situated on the El Camino Hospital campus.
Mission and Focus
Boomerang Medical's core mission is to leverage bioelectronic medicine as a transformative approach to managing autoimmune diseases, with a keen emphasis on IBD conditions such as Crohn's disease and ulcerative colitis. The company actively promotes IBD awareness and is a member of the Crohn’s & Colitis Foundation's Corporate Circle.
Technology and Innovation
The company’s proprietary technology centers on bioelectric neuromodulation, which uses the body's peripheral nervous system to manage inflammation. This groundbreaking approach has received Breakthrough Device Designation from the FDA and is currently being evaluated through FDA-approved clinical trials at leading IBD centers across the United States.
Leadership
Under the leadership of Heather Simonsen, President and CEO, Boomerang Medical charts a course toward technological advancement and clinical validation. The executive team includes instrumental figures such as David Miller (Chief Technology and Innovation Officer, Co-founder), Amy Lightner (Chief Medical Officer), and Colleen Holthe (VP of Clinical Affairs), supported by a dynamic team handling roles from clinical affairs to operations and communications.
Financials and Funding
Boomerang Medical has attracted a total of $18 million in funding through a single round, with venture capital backing from Arboretum Ventures and Hatteras Venture Partners. These investments highlight investor confidence in the company’s innovative capabilities and market potential.
Strategic Positioning
Strategically located in the heart of Silicon Valley, Boomerang Medical is well-positioned to leverage the region's vibrant ecosystem of medical technology innovation. Access to resources from Fogarty Innovation enhances the company’s positioning within the competitive landscape of bioelectronic medicine.
Recent Developments
The company has made significant progress by enrolling its first patients in a clinical trial to evaluate nerve stimulation as a treatment for Crohn's disease and ulcerative colitis, marking an important milestone in its efforts to offer groundbreaking solutions for autoimmune diseases.
Contact Information
- Address: 2495 Hospital Drive, Suite 300, Mountain View, CA 94040
- Phone: (844) 423-9747
- Email: info@boomerangmedical.com
Competitor Profiling
Market Position and Competitors
Boomerang Medical, a small but rapidly expanding entity in the biotechnology industry, operates amidst a robust competitor landscape without disclosed annual revenue figures. Its rapid employee growth, emphasized by a 63% increase in staffing, is a testament to its burgeoning influence and potential market impact.
Key Competitors
- SetPoint Medical: Known for its treatment of chronic autoimmune diseases through implantable neuromodulation devices, SetPoint Medical has secured FDA Breakthrough Device Designation and expanded through $80M in Preferred Stock Financing to advance autoimmune disease treatments.
- BioSig Technologies: A digital signal processing company specializing in arrhythmia detection and visualization, BioSig emphasizes innovative solutions for enhancing diagnostic efficiency and accuracy, focusing initially on heart rhythms.
- NextGen Jane: A women-focused health company leveraging molecular insights from menstrual blood to enhance diagnostics and treatment options for gynecological health issues. Despite its smaller size with 8 employees, NextGen Jane stands out in the Medical Equipment Manufacturing industry for its technological innovations.
- Herbarium: As a pioneer in phytotherapy within the Brazilian pharmaceutical sector, Herbarium specializes in herbal medicines and supplements, demonstrating gradual growth backed by robust research foundations.
- Valar Labs: Focuses on AI-driven diagnostics for solid tumors to assist treatment decision-making in cancer patients. Valar Labs, supported by Series A funding, concentrates on precision oncology to improve treatment certainty.
Position and Prospects in the Industry
Boomerang Medical engages in the biotechnology domain, challenged by entities like SetPoint Medical and Valar Labs, which offer specialized healthcare solutions. Its strategic emphasis on women-led initiatives and its locale within a renowned medical campus, in conjunction with key venture partnerships, bolster its prominence and credibility.
Boomerang Medical's focused strategy on bioelectronic medicine for autoimmune diseases aligns with the evolving demand for precision healthcare solutions, potentially positioning the company for significant market impact.
